# BUPIVACAINE HYDROCHLORIDE
> **ANDA216040** · Abbreviated New Drug Application (Generic) · Sponsor: MEITHEAL · Approved 2023-12-27
## Drug
- **FDA Application Number:** ANDA216040
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUPIVACAINE HYDROCHLORIDE
- **Generic name:** BUPIVACAINE HYDROCHLORIDE
- **Active ingredients:** BUPIVACAINE HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** MEITHEAL
- **Manufacturer:** Meitheal Pharmaceuticals Inc
- **First approval:** 2023-12-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216040)
---
*MORVS · CC0 1.0*